BEIJING - Six Chinese departments started a joint inspection on drug safety on Tuesday, according to a statement of the State Food and Drug Administration (SFDA).
According to the statement, the six departments will jointly focus on problems such as "media hype," the sale of fake drugs through mail, the implementation of state policies in the pharmaceutical sector, the restructuring of the sector and the implementation of drug quality standards, among others.